Name | N-(11H-dibenzo[1,2-a:1',2'-e][7]annulen-11-yl)-3-(4,5-dihydro-1,3-thiazol-2-yl)-1,3-thiazolidin-2-imine |
Synonyms | ERRα antagonist 1 N-(3-(4,5-Dihydrothiazol-2-yl)thiazolidin-2-ylidene)-5H-dibenzo[a,d][7]annulen-5-amine N-[3-(4,5-DIHYDRO-2-THIAZOLYL)-2-THIAZOLIDINYLIDENE]-5H DIBENZO[A,D] CYCLOHEPTEN-5-AMINE 5H-Dibenzo[a,d]cyclohepten-5-amine, N-[3-(4,5-dihydro-2-thiazolyl)-2-thiazolidinylidene]- |
CAS | 1072145-33-5 |
Molecular Formula | C21H19N3S2 |
Molar Mass | 377.53 |
Density | 1.36±0.1 g/cm3(Predicted) |
Boling Point | 579.0±60.0 °C(Predicted) |
pKa | 4.98±0.10(Predicted) |
Storage Condition | 2-8°C |
Sensitive | Irritant |
MDL | MFCD17676143 |
biological activity | ERR α angiist -1 (Compound A) is A selective, high-affinity estrogen-related receptor alpha (ERRα) antagonists. ERRα angionist -1 inhibits the interaction of ERRα with proliferator-activated receptor gamma coactivator 1α (PGC-1α) and PGC-1β with IC50 values of 170 nM and 180 nM, respectively. ERRα angionist -1 does not inhibit the interaction of ERR β or ERRγ with PGC-1α and PGC-1β coactivators, nor does it inhibit the interaction of ERα or ERβ with PGC-1α or SRC-1. |